InforSense® Announces Conference Series
News Nov 14, 2006
InforSense Ltd. has announced three upcoming InforSense-hosted conferences. The Statistical Genetics Workshop, co-chaired by Dr Jean-Pierre Kocher, Bioinformatics Core Director at the Mayo Clinic and Jonathan Sheldon, CSO at InforSense, will bring together thought leaders and practitioners in the Statistical Genetics arena to share case studies and best practices in this evolving field - from data cleaning to advanced statistical methods.
The Agenda features presentations from key players in the field and an open panel discussion. The agenda, list of registered speakers and registration form are available online.
The InforSense Users Conference will provide you with the opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Contributions from Keynote Speakers, InforSense KDE users, Partners and InforSense Product Specialists will help you to maximize the value of InforSense technology in your organization.
Register online to reserve your place and receive further information on the Users Conference.
The Translational Medicine Symposium will bring together thought leaders and practitioners in the Translational Medicine arena - from pharmaceutical and biotechnology organizations, biomedical research institutes and academia - to explore current trends, opportunities and unmet needs.
The Symposium will provide an opportunity for key players in the field to present the current practices through invited scientific and technical presentations.
It will also provide a forum to discuss the requirements for informatics between and across the many different disciplines that comprise Translational Medicine.
For the agenda, list of speakers and registration form visit Company website.
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE